Phaos Technology Holdings (Cayman) (POAS) Short term Debt (2024 - 2025)

Phaos Technology Holdings (Cayman) (POAS) reported Short term Debt of $56951.0 for Q4 2025, up 36.89% quarter-over-quarter from $41604.3 in Q2 2025.

Phaos Technology Holdings (Cayman) (POAS) Short term Debt (2024 - 2025) Analysis & Trends

Phaos Technology Holdings (Cayman) has reported Short term Debt for 2 years, with the latest figure at $56951.0 in Q4 2025.

For the quarter ending Q4 2025, Short term Debt changed N/A year-over-year to $56951.0; the trailing twelve-month figure through Oct 2025 stood at $56951.0 (changed N/A YoY), and the FY2025 full-year result was $41642.4, down 87.27% from the prior year.
Short term Debt for Q4 2025 stood at $56951.0, up from $41604.3 in the prior quarter.
The five-year high for Short term Debt was $327030.0 in Q2 2024, with the low at $41604.3 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn
10	Phaos Technology Holdings (Cayman)	682,234.12	627,245.12	-

Download Data